Tradestie Institutional Equity Comparison Engine

ABL vs IPOD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-05-26 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABL Overall Edge

ABL Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abacus Global Management, Inc. Class A Common Stock (ABL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABL trades at 8.6x Forward P/E with 35.6% operating margin (+123.7% YoY revenue) versus IPOD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ABL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IPOD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABL
ABL 8.6x vs IPOD N/M Fwd P/E
Growth & Margin Winner ABL
Op Margin 35.6% vs 0.0% ยท YoY +123.7% vs +0.0%
Momentum & Technical Winner ABL
1Y +12.3% vs +3.8% ยท 52W Pos 77% vs 100%
Options & Structure Winner ABL
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ABL NASDAQ
Abacus Global Management, Inc. Class A Common Stock
Investment Advice
$8.47
-0.35% 1D
Market Cap $830.9M
1M Return +29.51%
1Y Return +12.33%
Forward P/E 8.6x
Unified AI Score
61.3 / 100 BUY
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
IPOD US Equity
IPOD
Institutional Equity
$10.42
+0.39% 1D
Market Cap $210.0M
1M Return +0.97%
1Y Return +3.84%
Forward P/E N/M
Unified AI Score
58.0 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABL +12.33% IPOD +3.84% Spread: +43.37 pp (ABL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABL TTM Op. Margin: 35.6% IPOD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABL vs IPOD. Trailing 12-month operating profitability (ABL 35.6% vs IPOD 0.0%) and valuation multiples (ABL 8.6x vs IPOD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABL (7) vs IPOD (3)
Institutional Metric ABL IPOD Criterion Row Winner
Market Capitalization Scale $830.9M $210.0M Larger Scale ABL
Trailing P/E Ratio Valuation N/M 39.9x Lower Multiple IPOD
Forward P/E Ratio Valuation 8.6x N/M Lower Multiple ABL
Revenue Growth (YoY) Growth +123.7% +0.0% Higher Growth ABL
Operating Margin (TTM) Profitability 35.6% 0.0% Higher Margin ABL
Net Profit Margin Profitability 5.6% 0.0% Higher Margin ABL
Return on Equity (ROE) Capital Efficiency 3.2% 0.0% Higher ROE ABL
52-Week Range Position Momentum 77% ($5โ€“$10) 100% ($10โ€“$10) Stronger Trend IPOD
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 48% Vol 0.00ฮฒ ยท 2% Vol Lower Realized Risk IPOD
Unified Institutional Score Composite Signal 61.3 / 100 (BUY) 58.0 / 100 (HOLD) Higher Composite ABL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABL vs IPOD Buy Guide
ABL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IPOD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IPOD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABL nor IPOD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.